Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030Heather A. Parsons, Viktor A. Adalsteinsson, Timothy Blewett et al.|Annals of Oncology|2023Cited by 61
Comparison of whole‐genome and immunoglobulin‐based circulating tumor DNA assays in diffuse large B‐cell lymphomaReid W. Merryman, Viktor A. Adalsteinsson, Andjela Crnjac et al.|HemaSphere|2024Cited by 4
A Personalized Whole Genome-Informed Assay Targeting Single Mutant in Circulating Tumor DNA Can Identify MRD and Predict Relapse in DLBCLReid W. Merryman, Viktor A. Adalsteinsson, Justin Rhoades et al.|Blood|2023Cited by 2
Early MRD Detection after CAR-T Associated with Poor Outcome in Patients with Large B-Cell LymphomaNira A. Krasnow, Caron A. Jacobson, Katie Maurer et al.|Blood|2024Cited by 0